# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-020241
Filing Date
2021-08-16
Accepted
2021-08-16 17:03:16
Documents
54
Period of Report
2021-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 821402
2 |  | ex31-1.htm | EX-31.1 | 18959
3 |  | ex31-2.htm | EX-31.2 | 19066
4 |  | ex32-1.htm | EX-32.1 | 10459
| Complete submission text file | 0001493152-21-020241.txt |  | 4371414

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | ptix-20210630.xsd | EX-101.SCH | 34359
6 | XBRL CALCULATION FILE | ptix-20210630_cal.xml | EX-101.CAL | 41694
7 | XBRL DEFINITION FILE | ptix-20210630_def.xml | EX-101.DEF | 166909
8 | XBRL LABEL FILE | ptix-20210630_lab.xml | EX-101.LAB | 313141
9 | XBRL PRESENTATION FILE | ptix-20210630_pre.xml | EX-101.PRE | 250519
10 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 635118

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12555 | Film No.: 211179547
SIC: 7389 Services-Business Services, NEC